We demonstrated that the CD11b-DTR mice model is a suitable macrophage ablation model for ALTS1C1 brain tumor research and that F4/80+ macrophages and Ly6C− monocytes were selectively depleted, which enhanced the chemo-therapeutic effect while depletion without chemotherapy did not slow tumor progression. This evidence concerns the gene ITGAM and neoplasm.